Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-13
DOI
10.1038/s41598-019-55666-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-κB-TAK1-ERK1/2 axis in the context of PPARγ agonistic activity
- (2019) Sameh Saber et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Telmisartan ameliorates dextran sodium sulfate-induced colitis in rats by modulating NF-κB signalling in the context of PPARγ agonistic activity
- (2019) Sameh Saber et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Galangin Activates Nrf2 Signaling and Attenuates Oxidative Damage, Inflammation, and Apoptosis in a Rat Model of Cyclophosphamide-Induced Hepatotoxicity
- (2019) Aladaileh et al. Biomolecules
- Possible curative role of curcumin and silymarin against nephrotoxicity induced by gamma-rays in rats
- (2019) Nadia Abdel-Magied et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Renin–angiotensin system inhibition ameliorates CCl4-induced liver fibrosis in mice through the inactivation of nuclear transcription factor kappa B
- (2018) Sameh Saber et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia
- (2018) Licai He et al. EXPERIMENTAL CELL RESEARCH
- Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B
- (2018) Sameh Saber et al. TOXICOLOGY LETTERS
- Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study
- (2018) Yizhuo Wang et al. OncoTargets and Therapy
- Overexpression of the Ubiquilin-4 (UBQLN4) is Associated with Cell Cycle Arrest and Apoptosis in Human Normal Gastric Epithelial Cell Lines GES-1 Cells by Activation of the ERK Signaling Pathway
- (2018) Shengkai Huang et al. MEDICAL SCIENCE MONITOR
- Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy
- (2018) Feifei Liu et al. Acta Pharmaceutica Sinica B
- Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis
- (2018) Sameh Saber et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Candesartan and epigallocatechin-3-gallate ameliorate gentamicin-induced renal damage in rats through p38-MAPK and NF-κB pathways
- (2018) Hebatalla I. Ahmed et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Improvement in colistin-induced reproductive damage, apoptosis, and autophagy in testes via reducing oxidative stress by chrysin
- (2018) Emrah Hicazi Aksu et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk
- (2018) Sameh Saber et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma
- (2017) Sufang Yang et al. Oncology Letters
- The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma
- (2017) Cynthia M. Simbulan-Rosenthal et al. Oncotarget
- Silicon nanowire based biosensing platform for electrochemical sensing of Mebendazole drug activity on breast cancer cells
- (2016) Hani Shashaani et al. BIOSENSORS & BIOELECTRONICS
- OMP31 of Brucella melitensis 16M impairs the apoptosis of macrophages triggered by TNF-α
- (2016) Ke Zhang et al. Experimental and Therapeutic Medicine
- The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC
- (2016) Lei Li et al. Oncology Letters
- Fructus phyllanthi tannin fraction induces apoptosis and inhibits migration and invasion of human lung squamous carcinoma cells in vitro via MAPK/MMP pathways
- (2015) Hai-juan Zhao et al. ACTA PHARMACOLOGICA SINICA
- Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways
- (2015) Liqiang Qian et al. CANCER LETTERS
- Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma
- (2015) Jiang Chen et al. CANCER LETTERS
- Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma
- (2015) E. A. Kuczynski et al. CANCER RESEARCH
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations
- (2015) L. G. Ahronian et al. Cancer Discovery
- Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients
- (2015) Maria Serova et al. Oncotarget
- New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinoma
- (2014) Antoine Galmiche et al. CANCER LETTERS
- HBx Protein Promotes Oval Cell Proliferation by Up-Regulation of Cyclin D1 via Activation of the MEK/ERK and PI3K/Akt Pathways
- (2014) Heng-Yi Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting RAS–ERK signalling in cancer: promises and challenges
- (2014) Ahmed A. Samatar et al. NATURE REVIEWS DRUG DISCOVERY
- Unknown
- (2014) Walied Abdo et al. Turkish Journal of Fisheries and Aquatic Sciences
- Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells
- (2013) Martin Franz Sprinzl et al. HEPATOLOGY
- GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis
- (2013) R. Lencioni et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Molecular mechanisms of sorafenib action in liver cancer cells
- (2012) Melchiorre Cervello et al. CELL CYCLE
- Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma
- (2012) Masatoshi Kudo WORLD JOURNAL OF GASTROENTEROLOGY
- The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study
- (2011) M. Pinter et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen-activated protein kinases and AKT pathways
- (2011) Rie Matsushima-Nishiwaki et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- HCC and angiogenesis: possible targets and future directions
- (2011) Andrew X. Zhu et al. Nature Reviews Clinical Oncology
- Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
- (2011) Ren-Yuan Bai et al. NEURO-ONCOLOGY
- Partners in crime: the TGFβ and MAPK pathways in cancer progression
- (2011) Douglas A Chapnick et al. Cell and Bioscience
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3
- (2010) Fan Yang et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the RAF–MEK–ERK pathway in cancer therapy
- (2009) Clara Montagut et al. CANCER LETTERS
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells
- (2008) N. Doudican et al. MOLECULAR CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now